Literature DB >> 28750446

[Modern endoscopic imaging tools for urothelial carcinoma of the urinary bladder].

M C Kriegmair1, M Ritter1, M S Michel1, C Bolenz2.   

Abstract

Cystoscopy is the gold standard for the initial diagnosis of urothelial carcinoma in the urinary bladder (UCB). White light exhibits significant limitations in its ability to detect flat lesions or carcinoma in situ. Photodynamic Diagnosis (PDD) and Narrow Band Imaging (NBI) are established techniques which may improve the detection rates of UCB and reduce the risk of recurrence. Multiple novel tools have been developed in order to improve the diagnostic accuracy of endoscopic procedures, including Digital Contrast Enhancement Technology, Confocal Laser Endomicroscopy (CLE) and Optical Coherence Tomography (OCT). In future, spectral analysis of urothelial lesions may be achieved by Raman spectroscopy, thus providing information about biological alterations in the tissue. Furthermore, molecular imaging may allow specific targeting by fluorescent antibodies or small molecule agents, thus enabling differential diagnosis of suspicious lesions. Software-based approaches have been developed to incorporate computer-aided diagnosis and improve digital documentation of endoscopic findings. This study reviews current and future developments in the field of modern endoscopy of the urinary bladder and discusses the different approaches. © Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Year:  2017        PMID: 28750446     DOI: 10.1055/s-0043-109820

Source DB:  PubMed          Journal:  Aktuelle Urol        ISSN: 0001-7868            Impact factor:   0.658


  2 in total

Review 1.  [The development of real-time multispectral imaging for the diagnostics of bladder cancer].

Authors:  C Bolenz; J Rother; S Meessen; B Grychtol; A Majlesara; N Gharabaghi; C Günes; M Ritter; N Deliolanis; M S Michel; M C Kriegmair
Journal:  Urologe A       Date:  2019-12       Impact factor: 0.639

2.  Probe-based confocal laser endomicroscopy in detecting malignant lesions of vocal folds.

Authors:  M Goncalves; M Aubreville; S K Mueller; M Sievert; A Maier; H Iro; C Bohr
Journal:  Acta Otorhinolaryngol Ital       Date:  2019-01-31       Impact factor: 2.124

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.